guest ::
| Home > Publications database > IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma. > print |
| Home > Publications database > IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma. > print |
| 001 | 290039 | ||
| 005 | 20240512011049.0 | ||
| 024 | 7 | _ | |a 10.1093/neuonc/noad256 |2 doi |
| 024 | 7 | _ | |a pmid:38153426 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC11066906 |2 pmc |
| 024 | 7 | _ | |a 1522-8517 |2 ISSN |
| 024 | 7 | _ | |a 1523-5866 |2 ISSN |
| 024 | 7 | _ | |a altmetric:157843114 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2024-00944 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Obacz, Joanna |b 0 |
| 245 | _ | _ | |a IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma. |
| 260 | _ | _ | |a Oxford |c 2024 |b Oxford Univ. Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1715068320_19504 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Intrinsic or environmental stresses trigger the accumulation of improperly folded proteins in the endoplasmic reticulum (ER), leading to ER stress. To cope with this, cells have evolved an adaptive mechanism named the unfolded protein response (UPR) which is hijacked by tumor cells to develop malignant features. Glioblastoma (GB), the most aggressive and lethal primary brain tumor, relies on UPR to sustain growth. We recently showed that IRE1 alpha (referred to IRE1 hereafter), 1 of the UPR transducers, promotes GB invasion, angiogenesis, and infiltration by macrophage. Hence, high tumor IRE1 activity in tumor cells predicts a worse outcome. Herein, we characterized the IRE1-dependent signaling that shapes the immune microenvironment toward monocytes/macrophages and neutrophils.We used human and mouse cellular models in which IRE1 was genetically or pharmacologically invalidated and which were tested in vivo. Publicly available datasets from GB patients were also analyzed to confirm our findings.We showed that IRE1 signaling, through both the transcription factor XBP1s and the regulated IRE1-dependent decay controls the expression of the ubiquitin-conjugating E2 enzyme UBE2D3. In turn, UBE2D3 activates the NFκB pathway, resulting in chemokine production and myeloid infiltration in tumors.Our work identifies a novel IRE1/UBE2D3 proinflammatory axis that plays an instrumental role in GB immune regulation. |
| 536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a ER stress |2 Other |
| 650 | _ | 7 | |a IRE1 |2 Other |
| 650 | _ | 7 | |a chemokines |2 Other |
| 650 | _ | 7 | |a glioblastoma |2 Other |
| 650 | _ | 7 | |a inflammation |2 Other |
| 650 | _ | 7 | |a Endoribonucleases |0 EC 3.1.- |2 NLM Chemicals |
| 650 | _ | 7 | |a Protein Serine-Threonine Kinases |0 EC 2.7.11.1 |2 NLM Chemicals |
| 650 | _ | 7 | |a ERN1 protein, human |0 EC 2.7.11.1 |2 NLM Chemicals |
| 650 | _ | 2 | |a Glioblastoma: pathology |2 MeSH |
| 650 | _ | 2 | |a Glioblastoma: metabolism |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Endoribonucleases: metabolism |2 MeSH |
| 650 | _ | 2 | |a Endoribonucleases: genetics |2 MeSH |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Protein Serine-Threonine Kinases: metabolism |2 MeSH |
| 650 | _ | 2 | |a Protein Serine-Threonine Kinases: genetics |2 MeSH |
| 650 | _ | 2 | |a Signal Transduction |2 MeSH |
| 650 | _ | 2 | |a Brain Neoplasms: pathology |2 MeSH |
| 650 | _ | 2 | |a Brain Neoplasms: metabolism |2 MeSH |
| 650 | _ | 2 | |a Myeloid Cells: metabolism |2 MeSH |
| 650 | _ | 2 | |a Myeloid Cells: pathology |2 MeSH |
| 650 | _ | 2 | |a Unfolded Protein Response |2 MeSH |
| 650 | _ | 2 | |a Tumor Microenvironment |2 MeSH |
| 650 | _ | 2 | |a Tumor Cells, Cultured |2 MeSH |
| 650 | _ | 2 | |a Endoplasmic Reticulum Stress |2 MeSH |
| 700 | 1 | _ | |a Archambeau, Jérôme |b 1 |
| 700 | 1 | _ | |a Lafont, Elodie |b 2 |
| 700 | 1 | _ | |a Nivet, Manon |b 3 |
| 700 | 1 | _ | |a Martin, Sophie |b 4 |
| 700 | 1 | _ | |a Aubry, Marc |b 5 |
| 700 | 1 | _ | |a Voutetakis, Konstantinos |b 6 |
| 700 | 1 | _ | |a Pineau, Raphael |b 7 |
| 700 | 1 | _ | |a Boniface, Rachel |b 8 |
| 700 | 1 | _ | |a Sicari, Daria |b 9 |
| 700 | 1 | _ | |a Pelizzari-Raymundo, Diana |b 10 |
| 700 | 1 | _ | |a Ghukasyan, Gevorg |b 11 |
| 700 | 1 | _ | |a McGrath, Eoghan |b 12 |
| 700 | 1 | _ | |a Vlachavas, Efstathios-Iason |0 P:(DE-He78)f2f38d242b5d8cb3903e0ed098e8b554 |b 13 |u dkfz |
| 700 | 1 | _ | |a Le Gallo, Matthieu |b 14 |
| 700 | 1 | _ | |a Le Reste, Pierre Jean |b 15 |
| 700 | 1 | _ | |a Barroso, Kim |b 16 |
| 700 | 1 | _ | |a Fainsod-Levi, Tanya |b 17 |
| 700 | 1 | _ | |a Obiedat, Akram |b 18 |
| 700 | 1 | _ | |a Granot, Zvi |b 19 |
| 700 | 1 | _ | |a Tirosh, Boaz |b 20 |
| 700 | 1 | _ | |a Samal, Juhi |b 21 |
| 700 | 1 | _ | |a Pandit, Abhay |0 0000-0002-6292-4933 |b 22 |
| 700 | 1 | _ | |a Négroni, Luc |b 23 |
| 700 | 1 | _ | |a Soriano, Nicolas |b 24 |
| 700 | 1 | _ | |a Monnier, Annabelle |b 25 |
| 700 | 1 | _ | |a Mosser, Jean |b 26 |
| 700 | 1 | _ | |a Chatziioannou, Aristotelis |0 P:(DE-HGF)0 |b 27 |
| 700 | 1 | _ | |a Quillien, Véronique |b 28 |
| 700 | 1 | _ | |a Chevet, Eric |b 29 |
| 700 | 1 | _ | |a Avril, Tony |0 0000-0002-1129-8514 |b 30 |
| 773 | _ | _ | |a 10.1093/neuonc/noad256 |g Vol. 26, no. 5, p. 858 - 871 |0 PERI:(DE-600)2094060-9 |n 5 |p 858 - 871 |t Neuro-Oncology |v 26 |y 2024 |x 1522-8517 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:290039 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)f2f38d242b5d8cb3903e0ed098e8b554 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 27 |6 P:(DE-HGF)0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
| 914 | 1 | _ | |y 2024 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-10-24 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NEURO-ONCOLOGY : 2022 |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-24 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-24 |
| 915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b NEURO-ONCOLOGY : 2022 |d 2023-10-24 |
| 920 | 1 | _ | |0 I:(DE-He78)B050-20160331 |k B050 |l B050 Molekulare Genomanalyse |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B050-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|